Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
The Journal of Molecular Diagnostics : JMD
|
June 11, 2022
Alignment of Fellowship Training with Practice Patterns for Molecular Pathologists: A Report of the Association for Molecular Pathology Training and Education Committee
Priya D Velu, Allison Cushman-Vokoun, Mark D Ewalt, et al.
Haematologica
|
December 18, 2023
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine
Amanda C Winters, Mohd Minhajuddin, Brett M Stevens, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2024
Intratumoral T-cell composition predicts epcoritamab-based treatment efficacy in B-cell non-Hodgkin lymphomas
Lorenzo Falchi, Jahan Rahman, Lauren Melendez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 13, 2018
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group
Craig R Soderquist, Mark D Ewalt, David R Czuchlewski, et al.
Pediatric Blood & Cancer
|
October 10, 2019
Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors
Jessica A Lake, Andrew M Donson, Eric Prince, et al.
Blood Cancer Journal
|
August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
Giulio Cassanello, Esther Drill, Annie Qiu, et al.
The Journal of Molecular Diagnostics : JMD
|
December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms
Ying Liu, Caleb Ho, Wayne Yu, et al.
The Journal of Molecular Diagnostics : JMD
|
May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor Specimens
Mark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Blood Cancer Journal
|
June 16, 2026
Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors
Neerav Shukla, Karmelina Charalambous, Shanita Li, et al.
Blood Advances
|
October 25, 2019
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
Amanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
The Journal of Molecular Diagnostics : JMD
|
June 11, 2022
Alignment of Fellowship Training with Practice Patterns for Molecular Pathologists: A Report of the Association for Molecular Pathology Training and Education Committee
Priya D Velu, Allison Cushman-Vokoun, Mark D Ewalt, et al.
Haematologica
|
December 18, 2023
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine
Amanda C Winters, Mohd Minhajuddin, Brett M Stevens, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2024
Intratumoral T-cell composition predicts epcoritamab-based treatment efficacy in B-cell non-Hodgkin lymphomas
Lorenzo Falchi, Jahan Rahman, Lauren Melendez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 13, 2018
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group
Craig R Soderquist, Mark D Ewalt, David R Czuchlewski, et al.
Pediatric Blood & Cancer
|
October 10, 2019
Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors
Jessica A Lake, Andrew M Donson, Eric Prince, et al.
Blood Cancer Journal
|
August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
Giulio Cassanello, Esther Drill, Annie Qiu, et al.
The Journal of Molecular Diagnostics : JMD
|
December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms
Ying Liu, Caleb Ho, Wayne Yu, et al.
The Journal of Molecular Diagnostics : JMD
|
May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor Specimens
Mark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Blood Cancer Journal
|
June 16, 2026
Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors
Neerav Shukla, Karmelina Charalambous, Shanita Li, et al.
Blood Advances
|
October 25, 2019
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
Amanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, et al.
Page
of 5